Markets:

Overview

News

Currencies

International

Treasuries

MannKind Corporation - Common Stock (NQ:MNKD)

6.065 +0.095 (+1.59%)

Streaming Delayed Price Updated: 11:15 AM EST, Dec 19, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about MannKind Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >

41 Stocks Moving In Wednesday's Mid-Day Session ↗

March 02, 2022

Gainers ECMOHO Limited (NASDAQ: MOHO) jumped 67% to $0.3890 after jumping 10% on Tuesday. Nordstrom, Inc. (NYSE: JWN) shares jumped 38.7% to $27.11 after the company reported...

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

February 25, 2022

Gainers Surgalign Holdings (NASDAQ:SRGA) ...

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

February 25, 2022

During Friday's trading, 54 companies set new 52-week lows. Things to Consider About Today's 52-Week Lows: The largest company by market cap to hit a new 52-week...

Via Benzinga

Stocks That Hit 52-Week Lows On Monday ↗

February 28, 2022

On Monday morning, 66 companies achieved new lows for the year. Noteable 52-Week Lows: Gilead Sciences (NASDAQ:GILD) was the largest firm on a market cap basis to set a...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

February 24, 2022

Gainers Lantheus Holdings (NASDAQ:LNTH) stock rose 33.3% to $38.46 during Thursday's regular session. The current volume of 3.4 million shares is 876.7% of Lantheus...

Via Benzinga

93 Biggest Movers From Friday ↗

February 28, 2022

Gainers Inspirato Incorporated (NASDAQ: ISPO) shares surged 50.5% to close at $54.90. Guardforce AI Co., Limited (NASDAQ: GFAI) jumped 45.4% to settle at $0.5979 on Friday. EF...

Via Benzinga

45 Stocks Moving In Friday's Mid-Day Session ↗

February 25, 2022

Gainers KAR Auction Services, Inc. (NYSE: KAR) shares climbed 39.2% to $19.05 after the company agreed to sell its ADESA U.S. physical auction business to Carvana for $2.2...

Via Benzinga

44 Stocks Moving In Thursday's Mid-Day Session ↗

February 24, 2022

Gainers Indonesia Energy Corporation Limited (NYSE: INDO) shares climbed 66.7% to $12.55 following a 16% surge on Wednesday. Camber Energy, Inc. (NYSE: CEI) rose 45.2% to $0....

Via Benzinga

88 Biggest Movers From Yesterday ↗

February 25, 2022

Gainers Cyren Ltd. (NASDAQ: CYRN) shares surged 118.9% to settle at $4.75 on Thursday. Cyren recently announced a $12 million private placement. Indonesia Energy Corporation...

Via Benzinga

FDA Pushes United Therapeutics-MannKind Tyvaso DPI's Decision Date; United Therapeutics' Q4 Misses Consensus ↗

February 24, 2022

United Therapeutics Corp (NASDAQ: UTHR) and its partner MannKind Corp (NASDAQ: MNKD) have received an FDA information request letter for additional...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

February 23, 2022

Gainers SCYNEXIS (NASDAQ:SCYX) shares inc...

Via Benzinga

Executives Buy Over $2.7M Of 4 Penny Stocks ↗

February 03, 2022

Although producer prices in the Eurozone surged 26.2% year-over-year in December, hitting the highest level on record, there were a few notable insider trades.

Via Benzinga

Recap: MannKind Q3 Earnings ↗

November 09, 2021

MannKind (NASDAQ:MNKD) reported its Q3 earnings results on Tuesday, November 9, 2021 at 04:00 PM. Here's what investors need to know about the announcement. Earnings MannKind...

Via Benzinga

Wall Street Crime and Punishment: Martin Shkreli, The Self-Destructive Pharma Bro ↗

November 05, 2021

Does crime pay? Wall Street Crime and Punishment is a weekly series by Benzinga's Phil Hall chronicling the bankers, brokers and financial ne’er-do-wells whose ambition...

Via Benzinga

The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data ↗

November 09, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck Gets Antitrust Nod For Acceleron Deal In Germany, Austria, Announces...

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

October 28, 2021

Gainers Bellerophon Therapeutics (NASDAQ:

Via Benzinga

46 Biggest Movers From Yesterday ↗

October 19, 2021

Gainers Valneva SE (NASDAQ: VALN) shares surged 39.8% to close at $39.21 on Monday after the company reported VLA2001 met both co-primary endpoints in the Phase 3 pivotal trial...

Via Benzinga

Mid-Afternoon Market Update: Dow Falls 70 Points; Evolving Systems Shares Spike Higher ↗

October 18, 2021

Toward the end of trading Monday, the Dow traded down 0.20% to 35,223.86 while the NASDAQ rose 0.68% to 14,998.54. The S&P also rose, gaining 0.19% to 4,480.05. The U.S. has...

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Monday's Intraday Session ↗

October 18, 2021

Gainers Progenity (NASDAQ:PROG) shares increased by 33.17% to $2.85 during Monday's regular session. As of 12:30 EST, Progenity's stock is trading at a volume of...

Via Benzinga

Why Shares of MannKind Corporation Are Falling This Morning ↗

October 18, 2021

Investors are hyperventilating after a delay for its inhaled medicine.

Via The Motley Fool

Mid-Day Market Update: Nasdaq Rises 50 Points; Revance Therapeutics Shares Plummet ↗

October 18, 2021

Midway through trading Monday, the Dow traded down 0.05% to 35,275.96 while the NASDAQ rose 0.34% to 14,948.46. The S&P also rose, gaining 0.19% to 4,479.71. The U.S. has the...

Via Benzinga

Topics Stocks

34 Stocks Moving In Monday's Mid-Day Session ↗

October 18, 2021

Gainers Valneva SE (NASDAQ: VALN) shares jumped 34.6% to $37.75 after the company reported VLA2001 met both co-primary endpoints in the Phase 3 pivotal trial Cov-Compare....

Via Benzinga

MNKD Stock: The Disappointing FDA News That Has MannKind Shares Diving Today ↗

October 18, 2021

MannKind (MNKD) stock is taking a beating on Monday after releasing an update to investors concerning news from the FDA for Tyvaso DPI.

Via InvestorPlace

Why MannKind Shares Are Falling Today ↗

October 18, 2021

MannKind Corp (NASDAQ: MNKD) is trading significantly lower Monday morning after the company announced the FDA issued a complete response to United Therapeutics regarding the...

Via Benzinga

FDA Declines MannKind - United Therapeutics' Formulated Treprostinil For Lung Disease ↗

October 18, 2021

The FDA has issued a complete response to United Therapeutics Corporation (NASDAQ: UTHR) regarding the marketing application for Tyvaso DPI for pulmonary...

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

October 18, 2021

Gainers Valneva (NASDAQ:VALN) stock increased by 35.65% to $38.05 during Monday's pre-market session. The market value of their outstanding shares is at $1.8 billion....

Via Benzinga

Attention Biotech Investors: Mark Your Calendar For October PDUFA Dates ↗

October 01, 2021

Following a mixed month for regulatory approvals, biotech investors now turn toward a month of plenty as far as Food and Drug Administration decisions are concerned. Four new...

Via Benzinga

The Daily Biotech Pulse: Merck Confirms Acceleron Purchase, Regeneron Touts COVID-19 Antibody Cocktail Data, Takeda In-Licenses Huntington's Disease Drug ↗

September 30, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 29) Acceleron Pharma Inc. (...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

September 29, 2021

Gainers Regencell Bioscience (NASDAQ:RGC)...

Via Benzinga

MannKind's Return On Capital Employed Overview ↗

September 22, 2021

According to Benzinga Pro data, during Q2, MannKind (NASDAQ:MNKD) posted sales of $23.28 million. Earnings were up 9.95%, but MannKind still reported an overall loss of $9.03...

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.